PubRank

M Igartua

Author PubWeight™ 14.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 2002 1.08
2 Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. Vaccine 2004 1.02
3 Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials 2002 0.93
4 Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine 2001 0.84
5 Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Vaccine 2006 0.83
6 Novel extended-release formulation of lovastatin by one-step melt granulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2010 0.83
7 Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation. Int J Pharm 2003 0.82
8 Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres. Vaccine 2002 0.82
9 Survival of different cell lines in alginate-agarose microcapsules. Eur J Pharm Sci 2003 0.81
10 Microencapsulation of an anti-VE-cadherin antibody secreting 1B5 hybridoma cells. Biotechnol Bioeng 2001 0.80
11 Influence of shaking and surfactants on the release of bsa from plga microspheres. Eur J Drug Metab Pharmacokinet 1998 0.80
12 Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66. Int J Pharm 2003 0.78
13 Influence of dose and immunization route on the serum Ig G antibody response to BSA loaded PLGA microspheres. Vaccine 2002 0.78
14 Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes. Eur J Pharm Sci 2011 0.78
15 Production of BCG alginate-PLL microcapsules by emulsification/internal gelation. J Microencapsul 1997 0.77
16 Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. Mol Neurobiol 2015 0.76
17 Preparation and stability of agarose microcapsules containing BCG. J Microencapsul 2002 0.76
18 Design and characterization of calcium alginate microparticles coated with polycations as protein delivery system. J Microencapsul 2011 0.75
19 Immune responses to orally administered PLGA microparticles: influence of oil vehicles and surfactive agents. J Microencapsul 2003 0.75
20 Novel drug delivery systems for releasing growth factors to the CNS: focus on Alzheimer's and Parkinson's diseases. Mini Rev Med Chem 2014 0.75
21 Effect of lecithins on BCG-alginate-PLL microcapsule particle size and stability upon storage. J Microencapsul 2000 0.75
22 Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer's Disease After Implantation of VEGF-loaded PLGA Nanospheres. Curr Alzheimer Res 2015 0.75
23 Polymeric materials and formulation technologies for modified-release tablet development. Mini Rev Med Chem 2009 0.75
24 Determination of salbutamol enantiomers by high-performance capillary electrophoresis and its application to dissolution assays. J Pharm Biomed Anal 1997 0.75